United States · FDA National Drug Code directory
PROCYSBI
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 75987-145_46e1ad21-f347-4113-8ea1-2a0fcb129391
- Product NDC
- 75987-145
- Form
- GRANULE, DELAYED RELEASE
- Composition / generic term
- Cysteamine bitartrate
- Labeler
- Horizon Therapeutics USA, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20200214
- Source listing expiry
- 20271231
Source-listed ingredients
- CYSTEAMINE BITARTRATE — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 PACKET in 1 CARTON (75987-145-13) / 1 GRANULE, DELAYED RELEASE in 1 PACKET · 75987-145-13
- 120 PACKET in 1 CARTON (75987-145-14) / 1 GRANULE, DELAYED RELEASE in 1 PACKET · 75987-145-14
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →